| Literature DB >> 36231876 |
Georgia-Eirini Deligiannidou1, Chrysoula Kyrgou1, Evangelia Nena1,2, Vangelis G Manolopoulos3, Eugenia Bezirtzoglou1, Christos A Kontogiorgis1, Theodoros C Constantinidis1.
Abstract
BACKGROUND: Medicinal and aromatical plants (MAPs) have been historically used as traditional remedies in many cultures in Europe and globally. The aim of this study was to evaluate the use of MAPs in various health disorders in association to dietary habits and other lifestyle factors among residents in Thrace, NE Greece.Entities:
Keywords: Mediterranean diet; Thrace; aromatic and medicinal plants; epidemiology; natural products; northern Greece; nutrition
Mesh:
Year: 2022 PMID: 36231876 PMCID: PMC9566107 DOI: 10.3390/ijerph191912576
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 4.614
General demographics and socioeconomic distribution of the population.
| Male: | Female: | Total: | ||
|---|---|---|---|---|
| Age | Mean ± SD | 40.42 ± 11.26 | 39.23 ± 11.83 | 39.71 ± 11.61 |
| Age groups | 18–24 | 17 (7.6%) | 35 (10.6%) | 52 (9.4%) |
| 25–35 | 57 (25.6%) | 103 (31.3%) | 160 (29.0%) | |
| 36–45 | 76 (34.1%) | 87 (26.4%) | 163 (29.5%) | |
| 46–55 | 49 (22.0%) | 79 (24.0%) | 128 (23.2%) | |
| 56–65 | 21 (9.4%) | 22 (6.7%) | 43 (7.8%) | |
| >65 | 3 (1.3%) | 3 (0.9%) | 6 (1.1%) | |
| Marital | Married | 114 (50.4%) | 173 (51.6%) | 287 (51.2%) |
| Single | 73 (32.3%) | 83 (24.8%) | 156 (27.8%) | |
| In a relationship/cohabitation | 23 (10.2%) | 57 (17.0%) | 80 (14.3%) | |
| Divorced | 16 (7.1%) | 15 (4.5%) | 31 (5.5%) | |
| In widowhood | 0 (0.0%) | 7 (2.1%) | 7 (1.2%) | |
| Education | Primary/lower secondary school | 9 (3.9%) | 5 (1.5%) | 14 (2.5%) |
| Upper secondary school | 66 (29.2%) | 90 (26.9%) | 156 (27.8%) | |
| University graduate | 90 (39.8%) | 122 (36.4%) | 212 (37.7%) | |
| Master’s degree | 49 (21.7%) | 91 (27.2%) | 140 (25.0%) | |
| PhD degree | 12 (5.3%) | 27 (8.1%) | 39 (7.0%) | |
| Employment | Unemployed | 8 (3.5%) | 35 (10.5%) | 43 (7.7%) |
| Student | 18 (8.0%) | 37 (11.1%) | 55 (9.8%) | |
| Private employee | 40 (17.7%) | 39 (11.7%) | 79 (14.1%) | |
| State employee | 106 (46.9%) | 125 (37.4%) | 231 (41.3%) | |
| Part time job | 6 (2.7%) | 22 (6.6%) | 28 (5.0%) | |
| Freelancer | 34 (15.0%) | 46 (13.8%) | 80 (14.3%) | |
| Farmer/Breeder | 6 (2.7%) | 9 (2.7%) | 15 (2.7%) | |
| Retired/Household | 8 (3.5%) | 21 (6.3%) | 29 (5.2%) | |
| Family | <10,000 | 42 (18.9%) | 91 (28.4%) | 133 (24.5%) |
| 10,000–25,000 | 122 (55.0%) | 163 (50.9%) | 285 (52.6%) | |
| 25,000–40,000 | 52 (23.4%) | 59 (18.4%) | 111 (20.5%) | |
| >40,000 | 6 (2.7%) | 7 (2.2%) | 13 (2.4%) | |
| Smoking | No | 106 (46.9%) | 192 (57.3%) | 298 (53.1%) |
| Yes | 76 (33.6%) | 87 (26.0%) | 163 (29.1%) | |
| Yes, occasionally | 19 (8.4%) | 25 (7.5%) | 44 (7.8%) | |
| Quit for 1–5 years | 5 (2.2%) | 13 (3.9%) | 18 (3.2%) | |
| Quit for >6 years | 20 (8.8%) | 18 (5.4%) | 38 (6.8%) | |
| Alcohol | Never | 45 (19.9%) | 81 (24.2%) | 126 (22.5%) |
| <1 time/week | 96 (42.5%) | 165 (49.3%) | 261 (46.5%) | |
| 1–2 times/week | 54 (23.9%) | 73 (21.8%) | 127 (22.6%) | |
| 3–4 times/week | 25 (11.1%) | 11 (3.3%) | 36 (6.4%) | |
| > 4 times/week | 6 (2.7%) | 5 (1.5%) | 11 (2.0%) | |
| Exercise | Never | 33 (14.6%) | 57 (17.0%) | 90 (16.0%) |
| Occasionally but not often | 96 (42.5%) | 136 (40.6%) | 232 (41.4%) | |
| Regularly, <150 min/week | 51 (22.6%) | 78 (23.3%) | 129 (23.0%) | |
| Regularly, >150 min/week | 46 (20.4%) | 64 (19.1%) | 110 (19.6%) | |
| BMI | Mean ± SD | 27.41 ± 4.04 | 25.97 ± 5.61 | 26.55 ± 5.09 |
| BMI Groups | <18.5 | 0 (0.0%) | 6 (1.8%) | 6 (1.1%) |
| 18.5–24.9 | 75 (33.8%) | 164 (49.8%) | 239 (43.4%) | |
| 25–29.9 | 91 (41.0%) | 90 (27.4%) | 181 (32.8%) | |
| 30–34.9 | 50 (22.5%) | 48 (14.6%) | 98 (17.8%) | |
| >35 | 6 (2.7%) | 21 (6.4%) | 27 (4.9%) | |
Population demographics of positive responders.
| Common Use of MAPs, N (%) | Therapeutic Use of MAPs, N (%) | ||
|---|---|---|---|
| Sex | Male | 208 (38.4%) | 162 (39.6%) |
| Female | 333 (61.6%) | 247 (60.4%) | |
| Age groups | 18–24 | 49 (9.2%) | 40 (10.0%) |
| 25–35 | 156 (29.3%) | 115 (28.7%) | |
| 36–45 | 154 (28.9%) | 120 (29.9%) | |
| 46–55 | 125 (23.5%) | 90 (22.4%) | |
| 56–65 | 42 (7.9%) | 30 (7.5%) | |
| >65 | 6 (1.1%) | 6 (1.5%) | |
| Single (1) | No | 278 (65.3%) | 215 (64.8%) |
| Yes | 148 (34.7%) | 117 (35.2%) | |
| High education(2) | No | 160 (29.6%) | 129 (31.5%) |
| Yes | 381 (70.4%) | 280 (68.5%) | |
| Employment (3) | No | 72 (14.8%) | 61 (16.8%) |
| Yes | 416 (85.2%) | 303 (83.2%) | |
| Medium to high income and above (4) | No | 402 (77.0%) | 302 (76.8%) |
| Yes | 120 (23.0%) | 91 (23.2%) | |
(1): The groups of “Married” and “In relationship/cohabitation” were merged against all other groups; (2): the groups of “University graduate” and higher were merged against all other groups; (3): the groups of “Unemployed” and “Retired/Household” were merged against all other groups, and the group of “Students” was excluded; (4): the income groups were divided into two smaller subgroups: less than EUR 25,000 and more than EUR 25,000/annually.
Distribution of main MAPs used and causes of use.
| Main MAPs Used | Positive Responses | Main Causes of Use | Positive Responses |
|---|---|---|---|
| Chamomile | 301 (53.7) | Common cold | 265 (47.2) |
| Green tea | 239 (42.6) | Flu | 98 (17.5) |
| Black tea | 211 (37.6) | Insomnia/as a relaxant | 90 (16.0) |
| Mountain tea (local) | 167 (29.8) | Digestive disorders | 66 (11.8) |
| Aloysia | 102 (18.2) | As a stimulant | 66 (11.8) |
| Common sage | 96 (17.1) | Sore throat/pharyngitis | 65 (11.6) |
| Tilia (linden tea) | 75 (13.4) | For lipolysis | 45 (8.0) |
| Melissa | 71 (12.7) | Intestinal function | 35 (6.2) |
| Other | 71 (12.7) | For detoxification | 31 (5.5) |
| Mountain tea | 62 (11.1) | As a diuretic | 21 (3.7) |
* Percentages are calculated based on the overall sample of 561 participants.
Figure 1(A) % proportional distribution reflecting the cause of use for each MAP, (B) ranking of the top 5 MAPs in the conditions.
Figure 2(A) Positive responses on the use of MAPs before and after the COVID-19 pandemic was declared, distributed by sex (male; female; total). (B) Positive responses on MAPs choice before and after the COVID-19 pandemic was declared.
Figure 3(A) MAPs frequency of consumption during Period A (before COVID-19) and Period B (after COVID-19) (B) MAPs common cause of consumption during Period A and Period B.
Figure 4Consumed meals per day, food choices and % frequency of consumption. (A) Overall consumed meals per day: responses % for male and female participants, (B) overall food choices and % frequency of consumption for all responders (0 = never, 1 = 1–2 times per month, 2 = 2–3 times per month, 3 = 1–2 times per week, 4 = 3–4 times per week, 5 = 4–5 times per week, and 6 = daily).
Dietary habits of positive responders in the use of MAPs.
| Common Use of MAPs | Therapeutic Use of MAPs | ||||
|---|---|---|---|---|---|
| Male N (%) | Female N (%) | Male N (%) | Female N (%) | ||
| Fruit | No | 147 (70.7%) | 210 (63.1%) | 121 (74.7%) | 157 (63.6%) |
| Yes | 61 (29.3%) | 123 (36.9%) | 41 (25.3%) | 90 (36.4%) | |
| Vegetables | No | 157 (75.5%) | 213 (64.4%) | 127 (78.4%) | 163 (66.5%) |
| Yes | 51 (24.5%) | 118 (35.6%) | 35 (21.6%) | 82 (33.5%) | |
| Cereals | No | 133 (64.3%) | 200 (60.2%) | 99 (61.5%) | 150 (61.0%) |
| Yes | 74 (35.7%) | 132 (39.8%) | 62 (38.5%) | 96 (39.0%) | |
| Red meat | No | 23 (11.1%) | 20 (6.0%) | 16 (9.9%) | 12 (4.9%) |
| Yes | 185 (88.9%) | 312 (94.0%) | 146 (90.1%) | 234 (95.1%) | |
| Fish | No | 113 (54.3%) | 184 (55.8%) | 87 (53.7%) | 138 (56.3%) |
| Yes | 95 (45.7%) | 146 (44.2%) | 75 (46.3%) | 107 (43.7%) | |
| Milk | No | 107 (51.4%) | 164 (49.4%) | 88 (54.3%) | 118 (48.0%) |
| Yes | 101 (48.6%) | 168 (50.6%) | 74 (45.7%) | 128 (52.0%) | |
| Wine | No | 4 (1.9%) | 2 (0.6%) | 2 (1.2%) | 2 (0.8%) |
| Yes | 203 (98.1%) | 328 (99.4%) | 159 (98.8%) | 242 (99.2%) | |
| Olive oil | No | 145 (69.7%) | 232 (69.7%) | 117 (72.2%) | 170 (68.8%) |
| Yes | 63 (30.3%) | 101 (30.3%) | 45 (27.8%) | 77 (31.2%) | |
Figure 5(A): Odds Ratio outcomes regarding the common use of MAPs, (B): Odds Ratio outcomes regarding the use of MAPs in symptoms and common health disorders.